Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$32.4 - $68.18 $2,948 - $6,204
-91 Reduced 88.35%
12 $1,000
Q2 2022

Jul 28, 2022

BUY
$22.3 - $37.39 $223 - $373
10 Added 10.75%
103 $3,000
Q1 2022

Apr 21, 2022

BUY
$25.68 - $35.59 $282 - $391
11 Added 13.41%
93 $3,000
Q4 2021

Jan 31, 2022

SELL
$24.9 - $40.26 $2,938 - $4,750
-118 Reduced 59.0%
82 $2,000
Q1 2021

Sep 15, 2021

SELL
$38.94 - $50.85 $1,479 - $1,932
-38 Reduced 15.97%
200 $7,000
Q1 2021

Apr 27, 2021

BUY
$38.94 - $50.85 $1,479 - $1,932
38 Added 19.0%
238 $10,000
Q4 2020

Sep 15, 2021

SELL
$37.65 - $63.77 $4.09 Million - $6.93 Million
-108,596 Reduced 99.82%
200 $7,000
Q4 2020

Jan 27, 2021

BUY
$37.65 - $63.77 $4.09 Million - $6.93 Million
108,596 Added 54298.0%
108,796 $4.71 Million
Q3 2020

Sep 15, 2021

SELL
$52.76 - $74.49 $5.47 Million - $7.72 Million
-103,603 Reduced 99.81%
200 $7,000
Q3 2020

Oct 19, 2020

BUY
$52.76 - $74.49 $5.47 Million - $7.72 Million
103,603 Added 51801.5%
103,803 $5.72 Million
Q2 2020

Sep 15, 2021

SELL
$48.73 - $81.82 $3.71 Million - $6.23 Million
-76,161 Reduced 99.74%
200 $7,000
Q2 2020

Jul 22, 2020

BUY
$48.73 - $81.82 $3.71 Million - $6.23 Million
76,161 Added 38080.5%
76,361 $4.82 Million
Q1 2020

Sep 15, 2021

BUY
$41.72 - $87.2 $8,344 - $17,440
200 New
200 $7,000
Q1 2020

Apr 28, 2020

SELL
$41.72 - $87.2 $8,344 - $17,440
-200 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$45.7 - $81.86 $6,489 - $11,624
142 Added 244.83%
200 $7,000
Q4 2019

Jan 27, 2020

SELL
$45.7 - $81.86 $6,489 - $11,624
-142 Reduced 71.0%
58 $5,000
Q3 2019

Sep 14, 2021

BUY
$45.35 - $57.91 $9,070 - $11,582
200 New
200 $7,000
Q3 2019

Oct 22, 2019

SELL
$45.35 - $57.91 $9,070 - $11,582
-200 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$52.6 - $63.29 $10,520 - $12,658
200 New
200 $7,000
Q2 2019

Jul 31, 2019

SELL
$52.6 - $63.29 $10,520 - $12,658
-200 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$39.99 - $53.48 $7,998 - $10,696
200 New
200 $0

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.